The Valley Desk

NCT03875235 · Interventional trial

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

Overall registry status Active not recruiting

Phase 3

Conditions Biliary Tract Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov